Viruses & InfectionsWhat to know this winter

Eli Lilly Drug Fails to Prevent Alzheimer’s in Study

The drug was no better than placebo at averting the condition

Eli Lilly’s solanezumab was tested in more than 1,100 people with no signs of cognitive problems but who had clumps of the amyloid protein in their brains.Photo: MIKE SEGAR/REUTERS

An experimental drug from Eli Lilly & Co. failed to prevent memory loss in a study of healthy older people with a high risk of developing clinical Alzheimer’s disease in one of the first studies aimed at stopping symptoms before they start. 

The drug was no better than a placebo over about 4½ years of treatment at slowing patients’ decline in areas including memory and the ability to plan and complete tasks, Lilly said Wednesday.

What's News

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a member? Sign In

Sponsored Offers
  • TurboTax:
    TurboTax service code 2023 - $15 off
  • American Eagle Outfitters:
    15% off American Eagle promo code
  • Wayfair:
    Wayfair Coupon - 20% Off Sitewide
  • Kohl's:
    Save 15% on orders of $100+ with Kohl's coupon
  • Walmart:
    Walmart promo code 2023 - $20 off $50
  • DoorDash:
    50% off + free delivery on $20 orders with DoorDash promo code